NVO Ozempic - retraced from $148 to $102 - read the notes.
here is a link to a riview
NVO is Ozempic -Ozempic - retraced from $148 to $102 - and I bought the shares NVO, today Nov. 22, 2024 - Why?
November 22, 2024
Treating the entire USA population affected with type 2 Diabetes would cost $119 Billion USD. - not treating the population will costs $338 Billion in GDP losses. The answer is stupidly yes? must deliver Ozempic to all that need it.
IF I AM GOING TO ENDORSE SOMETHING THAT WORKS, IT WILL BE OZEMPIC. Period. No gimmicks, no images of ripped guys looking like wet chihuahuas, nothing like it—one injection in the belly once per week with a dosage pen, and you are done. After COVID, I became a whale, and now I have shed all those pounds gained from being cooped in for 2 years.Moderate exercise, once or twice per week, and Ozempic—that is it. The FUD about it that is being spread regarding weakness and intestinal paralysis is fake; none of it happened to me. I have nothing to gain by telling you this, except that I did buy the shares just now because they reached the Fib 61.8% retracement. I know this drug is effective and would be beneficial for many people who are morbidly obese in America because of food contamination, especially Crisco in most baking goods. So get healthy! Ozempic will boost your ability to make insulin by helping melt away internal fat surrounding your liver and pancreas, preventing it from contracting and expanding properly to make insulin. If you are diabetic type 2, if you lose weight to your BMI number, you will likely beat diabetes for good. Ozempic is a great biological technical innovation. We are past nature; if it were not for modern medicine, half of the world would be dead.
Why Ozempic is a Must Technological Innovation That Starts to Save Diabetics
Ozempic, containing the active ingredient semaglutide, represents a significant advancement in the management of type 2 diabetes. Its innovative mechanism not only helps control blood sugar levels but also addresses related health issues, making it a vital tool in diabetes care.
Global Impact of Type 2 Diabetes
Type 2 diabetes is a major health crisis worldwide. According to the International Diabetes Federation (IDF), approximately 537 million adults were living with diabetes in 2021, with this number expected to rise to 643 million by 2030. The disease is associated with severe complications, leading to significant mortality rates. In fact, diabetes and its complications account for an estimated 4.2 million deaths annually.
Lowering BMI and Restoring Insulin Production
Reducing body mass index (BMI) is crucial for improving the body's ability to regulate insulin production. Studies indicate that weight loss can enhance insulin sensitivity and restore proper pancreatic function. A lower BMI often correlates with better glycemic control, reducing the risk of diabetes-related complications. Research has shown that losing just5-10% of body weightcan lead to significant improvements in blood sugar levels and overall health.
The Need for Ozempic in Diabetes Management
While Ozempic has proven effective for many patients, there is still a substantial need for its widespread use to combat the growing epidemic of type 2 diabetes. Increased access to Ozempic could help millions manage their condition more effectively. The exact amount of Ozempic required to significantly curb the proliferation of type 2 diabetes is difficult to quantify, but expanding its availability and integrating it into treatment plans can make a substantial difference.
Economic Cost of Diabetes
The economic burden of diabetes on society is staggering. In the United States alone, the total estimated cost of diagnosed diabetes was$327 billion in 2017, which includes medical expenses and lost productivity. This figure continues to rise as more individuals are diagnosed with type 2 diabetes. The impact on GDP is profound, as healthcare costs associated with managing diabetes strain public health systems and reduce overall economic productivity.
Conclusion
Ozempic stands out as a revolutionary technological innovation that has the potential to save lives and improve the quality of life for those living with type 2 diabetes. By lowering BMI and enhancing insulin production, it addresses critical aspects of diabetes management. As we continue to face rising rates of this chronic condition, increasing access to effective treatments like Ozempic will be essential in mitigating its impact on individuals and society as a whole.
Your purchase of the stock NVO helps allocate resources more efficiently for this frm to grow and expand its reach and benefit to society. So when people ask you to invest responsible, you reply I do, I invest in things that are needed.
Recalculated Cost of Ozempic Treatment for Type 2 Diabetics in the USA
If we lower the cost of Ozempic to $330 per month, we can recalculate the total annual cost for treating all type 2 diabetics in the USA.
Estimating the Total Cost for All Type 2 Diabetics
Assuming there are approximately 30 million individuals with type 2 diabetes in the United States, the total annual cost can be calculated as follows:
Total Cost=Number of Patients×Annual Cost per Patient Total Cost=Number of Patients×Annual Cost per Patient
Total Cost=30,000,000×(330×12) = 30,000,000×3,960=118,800,000,000 Total Cost=30,000,000×(330×12)=30,000,000×3,960 = 118,800,000,000
Thus, the total estimated cost of Ozempic treatment for all type 2 diabetics in the USA would be around $119 billion annually.
Comparison with Economic Costs of Diabetes
Previously, we noted that the total estimated cost of diagnosed diabetes in the United States was approximately $327 billion in 2017. This figure encompasses medical expenses and lost productivity related to diabetes.
Conclusion: The Need for Continued Access to Ozempic
With the recalculated potential cost of providing Ozempic treatment to all type 2 diabetics at about $119 billion, this is significantly lower than the overall economic burden of diabetes.Given this context, it is crucial for the U.S. government to ensure that this critical therapy remains accessible to the entire population. Maintaining access to effective treatments like Ozempic is essential not only for improving health outcomes for individuals with diabetes but also for alleviating the broader economic impact associated with managing this chronic condition. Until comprehensive public health strategies can effectively address underlying issues such as food pollution and obesity, ensuring ongoing availability of Ozempic and similar therapies will be vital in combating type 2 diabetes in America.
You may also want to look into Crispr Therapeutics - this one is the next 500 Trillion company, it is like medicine pre-penicillin to now. Now we are going from antibiotic medicine to Gene Therapies tailored, new, effective, few collateral effects, and maybe even immortality. - and I bought the shares NVO, today Nov. 22, 2024 - Why?
NVO is Ozempic -Ozempic - retraced from $148 to $102 - and I bought the shares NVO, today Nov. 22, 2024 - Why?
November 22, 2024
Treating the entire USA population affected with type 2 Diabetes would cost $119 Billion USD. - not treating the population will costs $338 Billion in GDP losses. The answer is stupidly yes? must deliver Ozempic to all that need it.
IF I AM GOING TO ENDORSE SOMETHING THAT WORKS, IT WILL BE OZEMPIC. Period. No gimmicks, no images of ripped guys looking like wet chihuahuas, nothing like it—one injection in the belly once per week with a dosage pen, and you are done. After COVID, I became a whale, and now I have shed all those pounds gained from being cooped in for 2 years.Moderate exercise, once or twice per week, and Ozempic—that is it. The FUD about it that is being spread regarding weakness and intestinal paralysis is fake; none of it happened to me. I have nothing to gain by telling you this, except that I did buy the shares just now because they reached the Fib 61.8% retracement. I know this drug is effective and would be beneficial for many people who are morbidly obese in America because of food contamination, especially Crisco in most baking goods. So get healthy! Ozempic will boost your ability to make insulin by helping melt away internal fat surrounding your liver and pancreas, preventing it from contracting and expanding properly to make insulin. If you are diabetic type 2, if you lose weight to your BMI number, you will likely beat diabetes for good. Ozempic is a great biological technical innovation. We are past nature; if it were not for modern medicine, half of the world would be dead.
Why Ozempic is a Must Technological Innovation That Starts to Save Diabetics
Ozempic, containing the active ingredient semaglutide, represents a significant advancement in the management of type 2 diabetes. Its innovative mechanism not only helps control blood sugar levels but also addresses related health issues, making it a vital tool in diabetes care.
Global Impact of Type 2 Diabetes
Type 2 diabetes is a major health crisis worldwide. According to the International Diabetes Federation (IDF), approximately 537 million adults were living with diabetes in 2021, with this number expected to rise to 643 million by 2030. The disease is associated with severe complications, leading to significant mortality rates. In fact, diabetes and its complications account for an estimated 4.2 million deaths annually.
Lowering BMI and Restoring Insulin Production
Reducing body mass index (BMI) is crucial for improving the body's ability to regulate insulin production. Studies indicate that weight loss can enhance insulin sensitivity and restore proper pancreatic function. A lower BMI often correlates with better glycemic control, reducing the risk of diabetes-related complications. Research has shown that losing just5-10% of body weightcan lead to significant improvements in blood sugar levels and overall health.
The Need for Ozempic in Diabetes Management
While Ozempic has proven effective for many patients, there is still a substantial need for its widespread use to combat the growing epidemic of type 2 diabetes. Increased access to Ozempic could help millions manage their condition more effectively. The exact amount of Ozempic required to significantly curb the proliferation of type 2 diabetes is difficult to quantify, but expanding its availability and integrating it into treatment plans can make a substantial difference.
Economic Cost of Diabetes
The economic burden of diabetes on society is staggering. In the United States alone, the total estimated cost of diagnosed diabetes was$327 billion in 2017, which includes medical expenses and lost productivity. This figure continues to rise as more individuals are diagnosed with type 2 diabetes. The impact on GDP is profound, as healthcare costs associated with managing diabetes strain public health systems and reduce overall economic productivity.
Conclusion
Ozempic stands out as a revolutionary technological innovation that has the potential to save lives and improve the quality of life for those living with type 2 diabetes. By lowering BMI and enhancing insulin production, it addresses critical aspects of diabetes management. As we continue to face rising rates of this chronic condition, increasing access to effective treatments like Ozempic will be essential in mitigating its impact on individuals and society as a whole.
Your purchase of the stock NVO helps allocate resources more efficiently for this frm to grow and expand its reach and benefit to society. So when people ask you to invest responsible, you reply I do, I invest in things that are needed.
Recalculated Cost of Ozempic Treatment for Type 2 Diabetics in the USA
If we lower the cost of Ozempic to $330 per month, we can recalculate the total annual cost for treating all type 2 diabetics in the USA.
Estimating the Total Cost for All Type 2 Diabetics
Assuming there are approximately 30 million individuals with type 2 diabetes in the United States, the total annual cost can be calculated as follows:
Total Cost=Number of Patients×Annual Cost per Patient Total Cost=Number of Patients×Annual Cost per Patient
Total Cost=30,000,000×(330×12) = 30,000,000×3,960=118,800,000,000 Total Cost=30,000,000×(330×12)=30,000,000×3,960 = 118,800,000,000
Thus, the total estimated cost of Ozempic treatment for all type 2 diabetics in the USA would be around $119 billion annually.
Comparison with Economic Costs of Diabetes
Previously, we noted that the total estimated cost of diagnosed diabetes in the United States was approximately $327 billion in 2017. This figure encompasses medical expenses and lost productivity related to diabetes.
Conclusion: The Need for Continued Access to Ozempic
With the recalculated potential cost of providing Ozempic treatment to all type 2 diabetics at about $119 billion, this is significantly lower than the overall economic burden of diabetes.Given this context, it is crucial for the U.S. government to ensure that this critical therapy remains accessible to the entire population. Maintaining access to effective treatments like Ozempic is essential not only for improving health outcomes for individuals with diabetes but also for alleviating the broader economic impact associated with managing this chronic condition. Until comprehensive public health strategies can effectively address underlying issues such as food pollution and obesity, ensuring ongoing availability of Ozempic and similar therapies will be vital in combating type 2 diabetes in America.
You may also want to look into Crispr Therapeutics - this one is the next 500 Trillion company, it is like medicine pre-penicillin to now. Now we are going from antibiotic medicine to Gene Therapies tailored, new, effective, few collateral effects, and maybe even immortality. - and I bought the shares NVO, today Nov. 22, 2024 - Why?
註釋
By the way, I am enjoying writing abut stocks here at TradingView I encourage everyone to do the same, hopefully with long notes that serve us all to make good money allocation decisions. Warmest and good weekend.
In other words, I am endorsing this message board, lost of fun and very useful, and more useful with notes.
註釋
for example - our great Donald Trump would benefit from Ozempic. I would recommend it if I was his doctor..... like Trump many many others that keep a sedentary life doing mental work....
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。